Residual symptoms and relapse: Mood, cognitive symptoms, and sleep disturbances

Journal of Clinical Psychiatry

Volumn 74, Issue SUPPL. 2, 2013, Pages 9-13

  Zajecka, John M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AMNESIA; APATHY; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONCENTRATION LOSS; DAILY LIFE ACTIVITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FATIGUE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; RECURRENCE RISK; RELAPSE; REMISSION; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; TACHYPHYLAXIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84891475624     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12084su1c.02     Document Type: Article

References (31)

1. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31(9):1841-1853.
2. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998;50(2-3):97-108.
3. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9):1501-1504.
4. Nierenberg AA, Husain MM, Trivedi MH, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010;40(1):41-50.
5. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225.
6. Bolling MY, Kohlenberg RJ. Reasons for quitting serotonin reuptake inhibitortherapy: paradoxical psychological side effects and patient satisfaction. Psychother Psychosom. 2004;73(6):380-385.
7. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry. 2006;67(11):1754-1759.
8. McClintock SM, Husain MM, Wisniewski SR, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011;31(2):180-186.
9. Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41(6):1165-1174.
10. Nijrolder I, van der Windt D, de Vries H, et al. Diagnoses during follow-up of patients presenting with fatigue in primary care. CMAJ. 2009;181(10):683-687.
11. Neu D, Linkowski P, le Bon O. Clinical complaints of daytime sleepiness and fatigue: how to distinguish and treat them, especially when they become 'excessive' or 'chronic'? Acta Neurol Belg. 2010;110(1):15-25.
12. Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primarycare study. Psychol Med. 1995;25(5):895-905.
13. Addington AM, Gallo JJ, Ford DE, et al. Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981-1994. Psychol Med. 2001;31(6):1037-1044.
14. Kroenke K, Wood DR, Mangelsdorff AD, et al. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA. 1988;260(7):929-934.
15. Leone SS. A disabling combination: fatigue and depression. Br J Psychiatry. 2010;197(2):86-87.
16. Matza LS, Phillips GA, Revicki DA, et al. Development and validation of a patientreport measure of fatigue associated with depression. J Affect Disord. 2011;134(1-3):294-303.
17. Traeger L, Braun IM, Greer JA, et al. Parsing depression from fatigue in patients with cancer using the fatigue symptom inventory. J Pain Symptom Manage. 2011;42(1):52-59.
18. Lam RW, Michalak EE, Bond DJ, et al. Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depress Res Treat. 2012;2012(630206).
19. Naismith SL, Longley WA, Scott EM, et al. Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry. 2007;7(1):32.
20. Jaeger J, Berns S, Uzelac S, et al. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145(1):39-48.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
22. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.
24. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389.
25. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477-486.
26. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583.
27. Leon AC, Olfson M, Portera L, et al. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997;27(2):93-105.
28. Fava M, Iosifescu DV, Pedrelli P, et al. Reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire. Psychother Psychosom. 2009;78(2):91-97.
29. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition. Washington, DC: American Psychiatric Association; 2010. http://psychiatryonline.org/content. aspx?bookid=2 8§ionid=1667485. Accessed July 30, 2013.
30. Rothschild AJ, Dunlop BW, Dunner DL, et al. Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study. Psychopharmacol Bull. 2009;42(3):5-20.
31. Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatmentv with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry. 1997;58(7):291-297.